grey market retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug How 'grey market' sellers in

While Wegovy is the only Semaglutide product specifically approved by the FDA for weight loss (Novo), its counterparts, Ozempic and Rybelsus, are only approved for managing diabetes (FDA U.S

When appetite drops, patients may eat less food, drink less fluid, reduce fiber intake, or move less

The primary symptoms of PCOS include: Irregular or absent menstrual cycles Excessive hair growth (hirsutism) on the face, chin, or body Acne and oily skin Weight gain or difficulty losing weight PCOS can disrupt the body's ability to regulate insulin, leading to weight fluctuations and metabolic challenges

Progression to KRT occurred in 2.5% of patients receiving SGLT2 inhibitors